Related by context. Frequent words. (Click for all words.) 70 Phase Ib clinical 69 placebo controlled Phase 69 placebo controlled clinical 67 PRECiSE 67 phase IIa 66 RRMS patients 66 SABCS 66 Pivotal Phase III 64 prospective observational 64 placebo controlled clinical trials 64 COPAXONE R 64 placebo controlled studies 64 dose cohorts 63 ZD# [001] 63 Traficet EN 63 Pirfenidone 63 randomized Phase III 63 Multicenter 63 placebo controlled trials 63 axitinib 63 phase 2a 62 elotuzumab 62 phase IIb clinical 62 LymphoStat B 62 EORTC 62 patients evaluable 62 GSK# [001] 62 Clinical Trial Results 62 TRITON TIMI 62 Natalizumab 61 randomized controlled clinical trials 61 Epratuzumab 61 Solid Tumors 61 tocilizumab 61 Phase Ib 61 Pivotal Trial 61 Pivotal Phase 61 Carfilzomib 61 Sym# 61 Rosuvastatin 61 MIRCERA 61 Immunogenicity 61 secondary efficacy endpoints 61 nab paclitaxel 61 Targeted Therapy 61 Phase III randomized 61 HER2 positive metastatic breast 61 myeloproliferative disorders 61 Alemtuzumab 61 subgroup analyzes 61 randomized controlled clinical 60 Pharmacokinetic 60 Phase 1b trial 60 evaluable patients 60 Amrubicin 60 TORISEL 60 double blinded placebo 60 bevacizumab Avastin 60 HSCT 60 TYKERB 60 phase IIb 60 metastatic hormone refractory 60 Thrombolysis 60 Phase 2a 60 placebo controlled randomized 60 tolvaptan 60 PROMACTA 60 mycophenolate mofetil 60 Phase 1b 60 Phase III Clinical Trial 60 romiplostim 59 Phase 2a trial 59 Phase 1b clinical 59 Preclinical Data 59 dose regimens 59 Meta Analysis 59 Cethromycin 59 SPIRIT IV 59 Apixaban 59 NVA# 59 glatiramer acetate 59 multicentre 59 Chronic Lymphocytic Leukemia 59 abiraterone acetate 59 interferon beta 1b 59 SWOG 59 NLX P# 59 SPIRIT III 59 ALLHAT 59 multicenter clinical 59 substudy 59 multicenter randomized 59 Metastatic Melanoma 59 prospective randomized controlled 59 ponatinib 59 events SAEs 59 Cloretazine R VNP#M 59 ascending doses 59 relapsed refractory multiple myeloma 59 Phase III Trial 59 ACTEMRA